Abstract: A process can be used to produce N-vinyl compounds by homogeneous catalysis. In the process, acetylene is reacted with a cyclic compound having at least one nitrogen as a ring member, hearing a substitutable hydrogen residue (cyclic compound C), in a liquid phase in the presence of a ruthenium complex containing at least one phosphine as a ligand (RuCat).

Abstract: The present invention relates to the discovery of novel genes encoding RIEG polypeptides. Therapeutics, diagnostics and screening assays based on these molecules are also disclosed.

Abstract: The present invention relates to the discovery of novel genes encoding RGS polypeptides. Therapeutics, diagnostics and screening assays based on these, molecules are also disclosed.

Abstract: The present invention relates to the discovery of novel genes encoding RGS polypeptides. Therapeutics, diagnostics and screening assays based on these molecules are also disclosed.

Abstract: The invention provides nucleic acids encoding Pitx3 polypeptides, fragments thereof and homologs thereof and Pitx3 polypeptides encoded thereby. Pitx3 polypeptides play an important role in development of eye structures, e.g., the lens, and was shown herein to be associated with the formation of cataracts and Anterior Segment Mesenchymal Dysgenesis (ASMD). Thus, the invention provides methods for predicting whether a subject has or is at risk of developing cataracts or other disease associated with an aberrant Pitx3, by determining, e.g., whether the subject has a genetic lesion in a Pitx3 gene, such as a 17 bp insertion, characteristic of cataract development and ASMD or a base pair substitution at codon 13. Methods for treating cataracts or diseases or conditions associated with an aberrant Pitx3, e.g., by administering to the subject a Pitx3 therapeutic, are also disclosed, as well as assays for identifying Pitx3 therapeutics.